Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,816,931
  • Shares Outstanding, K 127,752
  • Annual Sales, $ 642,820 K
  • Annual Income, $ -43,540 K
  • EBIT $ -61 M
  • EBITDA $ -17 M
  • 60-Month Beta 2.17
  • Price/Sales 4.22
  • Price/Cash Flow N/A
  • Price/Book 3.18

Options Overview Details

View History
  • Implied Volatility 101.43% (+13.76%)
  • Historical Volatility 75.13%
  • IV Percentile 92%
  • IV Rank 66.18%
  • IV High 127.16% on 04/23/25
  • IV Low 51.09% on 08/21/25
  • Expected Move (DTE 15) 3.80 (17.23%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 3,304
  • Volume Avg (30-Day) 883
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 13,296
  • Open Int (30-Day) 10,585
  • Expected Range 18.25 to 25.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.25
  • Number of Estimates 8
  • High Estimate $-0.06
  • Low Estimate $-0.41
  • Prior Year $-0.36
  • Growth Rate Est. (year over year) +30.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.90 +38.68%
on 03/16/26
23.30 -5.36%
on 03/03/26
-1.00 (-4.34%)
since 02/27/26
3-Month
15.90 +38.68%
on 03/16/26
23.56 -6.41%
on 01/23/26
+5.74 (+35.19%)
since 12/31/25
52-Week
6.78 +225.22%
on 04/07/25
23.56 -6.41%
on 01/23/26
+13.38 (+154.33%)
since 04/01/25

Most Recent Stories

More News
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know

Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know

TXG : 22.05 (+3.86%)
PACB : 1.3500 (+2.27%)
OSCR : 11.73 (+2.27%)
AZTA : 21.18 (+0.24%)
MRNA : 50.03 (-1.52%)
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs

The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world today...

TXG : 22.05 (+3.86%)
Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs

The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale over existing data available in the world today...

TXG : 22.05 (+3.86%)
3 Reasons to Sell TXG and 1 Stock to Buy Instead

3 Reasons to Sell TXG and 1 Stock to Buy Instead

TXG : 22.05 (+3.86%)
PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas

- Fueled by best-in-class technology and deep expertise in genome engineering and AI, PerturbAI is uniquely positioned to redefine therapeutic discovery, making it more scalable, translatable and cost-efficient...

TXG : 22.05 (+3.86%)
1 Cash-Producing Stock with Competitive Advantages and 2 We Ignore

1 Cash-Producing Stock with Competitive Advantages and 2 We Ignore

BURL : 330.83 (+1.67%)
TXG : 22.05 (+3.86%)
RCL : 282.06 (+2.50%)
3 Healthcare Stocks We’re Skeptical Of

3 Healthcare Stocks We’re Skeptical Of

TXG : 22.05 (+3.86%)
LMAT : 108.75 (-0.38%)
MRNA : 50.03 (-1.52%)
3 Russell 2000 Stocks We Approach with Caution

3 Russell 2000 Stocks We Approach with Caution

TXG : 22.05 (+3.86%)
PWP : 18.00 (-0.88%)
BKD : 13.86 (+1.32%)
Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers

Life Sciences Tools & Services Stocks Q4 In Review: 10x Genomics (NASDAQ:TXG) Vs Peers

TXG : 22.05 (+3.86%)
3 Stocks Under $50 We’re Skeptical Of

3 Stocks Under $50 We’re Skeptical Of

TXG : 22.05 (+3.86%)
SBH : 14.16 (+2.24%)
PEGA : 42.29 (-0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 24.31
2nd Resistance Point 23.68
1st Resistance Point 22.87
Last Price 22.05
1st Support Level 21.43
2nd Support Level 20.80
3rd Support Level 19.99

See More

52-Week High 23.56
Last Price 22.05
Fibonacci 61.8% 17.15
Fibonacci 50% 15.17
Fibonacci 38.2% 13.19
52-Week Low 6.78

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.